Samsung Bioepis

Samsung Bioepis Co., Ltd. is a biopharmaceutical company based in Incheon, South Korea, specializing in the development and production of biosimilar products. Established in 2012, the company aims to enhance patient access to high-quality treatment options through its extensive pipeline of biosimilar candidates. Samsung Bioepis focuses on innovative therapies targeting various health conditions, including neurodegenerative diseases, hemophilia, and autoimmune disorders. The company has formed a strategic collaboration with Takeda Pharmaceutical Company, further strengthening its position in the biopharmaceutical industry. By leveraging process innovation, Samsung Bioepis strives to provide improved healthcare solutions for patients worldwide.